JAMES FAY, MD

Insertion of spinal neurostimulator electrode array through skin

Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint

Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint

Insertion of spinal neurostimulator generator or receiver

Injection of upper or middle spine facet joint using imaging guidance, single level

Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance

Injection of lower or sacral spine facet joint using imaging guidance, single level

Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level

Injection of substance into middle or upper spine canal using imaging guidance

Injection of substance into lower spine canal using imaging guidance

Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint

Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint

Injection of upper or middle spine facet joint using imaging guidance, second level

Injection of lower or sacral spine facet joint using imaging guidance, second level

New patient office or other outpatient visit, 45-59 minutes

Fluoroscopic guidance for needle placement

Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level

Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms

Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms

Aspiration and/or injection of fluid from large joint

Established patient office or other outpatient visit, 30-39 minutes

Injection of trigger points, 3 or more muscles

Injection of trigger points, 1-2 muscles

Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming

Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes

Telephone medical discussion with physician, 11-20 minutes

Testing for presence of drug, read by direct observation

Device supply with scheduled recording and transmission for remote monitoring of musculoskeletal system, per 30 days

Remote therapeutic monitoring treatment management services by physician or other qualified health care professional, first 20 minutes per calendar month

Remote therapeutic monitoring treatment management services by physician or other qualified health care professional, each additional 20 minutes per calendar month

Set-up and patient education for remote monitoring of therapy

Injection, dexamethasone sodium phosphate, 1 mg